Cross Country Healthcare, Inc. (NASDAQ:CCRN) Given Average Rating of "Hold" by Analysts

Shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Get Free Report) have been assigned a consensus rating of "Hold" from the six analysts that are covering the firm, Marketbeat reports. Six analysts have rated the stock with a hold rating. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $17.93.

CCRN has been the topic of a number of analyst reports. Barrington Research reaffirmed a "market perform" rating and set a $18.61 price objective on shares of Cross Country Healthcare in a report on Tuesday, June 17th. UBS Group cut their price target on shares of Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating on the stock in a report on Tuesday, May 13th. Finally, Wall Street Zen began coverage on shares of Cross Country Healthcare in a report on Thursday, May 15th. They issued a "hold" rating on the stock.

Cross Country Healthcare Price Performance

CCRN opened at $12.98 on Friday. The company has a market capitalization of $425.48 million, a price-to-earnings ratio of -24.49, a P/E/G ratio of 3.99 and a beta of 0.36. The firm's fifty day moving average price is $13.48 and its two-hundred day moving average price is $15.56. Cross Country Healthcare has a 1 year low of $9.58 and a 1 year high of $18.50.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 1.41% and a positive return on equity of 2.56%. The firm's revenue was down 22.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.19 EPS. As a group, equities analysts anticipate that Cross Country Healthcare will post 0.53 EPS for the current year.

Hedge Funds Weigh In On Cross Country Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Magnetar Financial LLC bought a new stake in Cross Country Healthcare in the 4th quarter valued at about $41,421,000. Alliancebernstein L.P. increased its position in shares of Cross Country Healthcare by 82.4% in the first quarter. Alliancebernstein L.P. now owns 2,343,484 shares of the business services provider's stock worth $34,894,000 after purchasing an additional 1,058,544 shares during the last quarter. Alpine Associates Management Inc. boosted its stake in Cross Country Healthcare by 115.6% in the first quarter. Alpine Associates Management Inc. now owns 1,252,524 shares of the business services provider's stock worth $18,650,000 after buying an additional 671,492 shares in the last quarter. AQR Arbitrage LLC purchased a new stake in Cross Country Healthcare in the fourth quarter worth approximately $10,851,000. Finally, Chicago Capital Management LLC purchased a new stake in shares of Cross Country Healthcare during the fourth quarter valued at approximately $7,300,000. 96.03% of the stock is owned by hedge funds and other institutional investors.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.